You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
美單週新增近56萬宗新冠確診 上月新增確診按月升逾兩倍
阿思達克 08-02 15:08
美國新冠疫情惡化。據美國約翰霍普金斯大學數據,截至美國西岸間午夜(本港時間下午3時),美國累欣新冠確診突破3,500萬宗,達35,003,523宗,按周增加559,702宗,爲今年2月中以來最多,較對上一週增加54%。累計死亡人數613,228宗,按周增加2,337宗。較對上一週加25%。

美國上月錄得逾130萬宗新冠確診個案,爲6月的三倍有多。美國國家過敏和傳染病研究所所長福奇承認部分確診者已完成接種新冠疫苗,又指沒有疫苗能提供百分百保護,但以病重程度、入院及死亡率計,未接種疫苗人士更受病毒影響。芝加哥部分醫護中心要求員工9月1日前完成疫苗接種,內華達州州政府要求未接種疫苗員工8月中起每週提交檢測報告。

佛羅裏達州昨日(1日)新冠留院個案破頂,達10,270宗,高於去年7月23日的10,170宗紀錄。但該州州長仍堅拒口罩令,限制地方政府實施口罩令權限,亦簽署指令保障家長權利,使當地學校不能規定學生戴口罩回校。

以下爲美國過去七日新冠疫情統計:

日期│累計確診│單日新增確診│累計死亡│單日新增死亡

8月 1日(日)│35,003,523宗│+ 25,062宗│613,228宗│+ 71宗

7月31日(六)│34,978,461宗│+ 32,263宗│613,157宗│+142宗

7月30日(五)│34,946,198宗│+195,165宗│613,015宗│+893宗

7月29日(四)│34,751,033宗│+ 78,211宗│612,122宗│+321宗

7月28日(三)│34,672,822宗│+ 68,825宗│611,801宗│+513宗

7月27日(二)│34,603,997宗│+ 70,818宗│611,288宗│+336宗

7月26日(一)│34,533,179宗│+ 89,358宗│610,952宗│+ 61宗

以下爲美國過去七週新冠疫情統計:

日期│七日累計確診│七天日均新增確診│七日累計死亡│七天日均新增死亡

截至8月 1日(日)│559,702宗│+79,957宗│2,337宗│+334宗

截至7月25日(日)│363,861宗│+51,980宗│1,872宗│+267宗

截至7月18日(日)│226,012宗│+32,287宗│1,863宗│+266宗

截至7月11日(日)│136,374宗│+19,482宗│1,630宗│+233宗

截至7月 4日(日)│ 92,538宗│+13,220宗│1,559宗│+228宗

截至6月27日(日)│ 70,717宗│+10,102宗│1,875宗│+268宗

截至6月20日(日)│ 79,937宗│+11,420宗│2,055宗│+294宗

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account